Olfr917, a member of the olfactory receptor family, is a critical component of the olfactory system in mice. Its primary function is to detect odorant molecules and initiate neuronal responses that lead to the perception of various smells. Olfr917 belongs to the G-protein-coupled receptor (GPCR) family, which is essential for odorant signal transduction. Regarding inhibition, it's important to note that direct chemical inhibitors for olfactory receptors like Olfr917 are not commonly employed due to their specialized function in odor detection. However, we have explored various chemicals that target signaling pathways related to olfaction, which might indirectly influence Olfr917. These pathways encompass cAMP-PKA, MAPK, calcium signaling, JAK-STAT, NF-κB, mTOR, and GPCR signaling. Chemicals like Rolipram, U0126, Pertussis Toxin, H-89, KN-93, Rapamycin, AG-490, BAY 11-7082, SB 203580, PD98059, KT5720, and KN-62 have been identified as potential inhibitors of these pathways, presenting opportunities for further research into Olfr917 inhibition.
In summary, Olfr917 is a critical player in the olfactory system of mice, responsible for detecting odorant molecules and initiating neural responses that lead to the perception of odors. While direct chemical inhibitors for olfactory receptors like Olfr917 are not commonly used, targeting signaling pathways associated with olfaction can potentially serve as indirect inhibitors, influencing Olfr917's expression and function. These pathways play a crucial role in regulating olfactory receptor gene expression and function, making them subjects of interest for future investigations into Olfr917 inhibition.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Rolipram inhibits PDE4, leading to increased cAMP levels and potentially influencing Olfr917 signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 is a MEK inhibitor that could indirectly affect Olfr917 function by targeting the MAPK pathway. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $442.00 | 3 | |
Pertussis Toxin inhibits GPCR signaling, potentially influencing Olfr917 function indirectly. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
KN-93 is a selective inhibitor of CaMKII, influencing calcium signaling, which could indirectly impact Olfr917 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin targets mTOR, a regulator of protein synthesis, indirectly affecting Olfr917 expression and function. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
AG-490 inhibits JAK2, potentially influencing sensory neuron development related to olfaction and Olfr917. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
BAY 11-7082 inhibits NF-κB, which may indirectly influence immune responses in the nasal epithelium related to Olfr917. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB 203580 inhibits p38 MAPK, associated with the MAPK pathway in olfaction, indirectly affecting Olfr917 function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is a specific MEK inhibitor that could indirectly affect olfaction-related signaling pathways and Olfr917. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $97.00 $144.00 $648.00 | 47 | |
KT5720 is a selective PKA inhibitor, affecting cAMP-PKA pathway, which may influence olfactory signal transduction. |